Keywords: anges, pays, vical, 3m, allovectin-7, trial, drugmaker

AnGes pays Vical $6.3M for Allovectin-7 trial

Article | 23 June 2008

US drugmaker Vical has received $6.3 million in cash payments and equity investments from Japanese drugmaker AnGes MG, under a previously-announced ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

3M

Go to company listing